IP Library Granted Patent US 12,168,804
Granted Patent B2
US 12,168,804 · App. 16/632,051 · Granted Dec 17, 2024

Patent

Inventors: Mika Tsuna (Atsugi, JP); Yoshitaka Harada (Atsugi, JP); Yasuhiro Seto (Atsugi, JP); Kazuto Takasaki (Atsugi, JP)
Assignees: NIPPN CORPORATION; FASMAC CO., LTD.
C12Q1/689C12Q1/6853C12Q1/686C12Q1/6869G01N33/52C12Q2600/156G01N2458/00G01N2469/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,168,804
App. No.
16/632,051
Granted
Dec 17, 2024
Kind
B2
Abstract

Novel means that enables detection of the monocytogenes bacterium alone distinctly from other bacteria belonging to the genus Listeria with sufficiently high accuracy is disclosed. The present inventors intensively analyzed the genome of the monocytogenes bacterium to identify two genes (the lmo0084 gene and the lmo2736 gene) as target regions with which the monocytogenes bacterium can be specifically detected distinctly from other bacteria belonging to the genus Listeria utilizing a nucleic acid amplification method. By a further intensive study of the base sequences of these two genes, primer setting regions for highly accurate, specific detection of the monocytogenes bacterium alone were identified, and preferred particular examples of PCR primer sets, LAMP primer sets, and real-time PCR primer-probe sets were established.

Claims (52)

1. A primer set for detection of Listeria monocytogenes , comprising any of the following primer sets for amplification of a partial region of lmo0084 gene or lmo2736 gene of Listeria monocytogenes:

(A-1) a set of a forward primer containing in its 3′-side the base sequence of SEQ ID NO:26 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence, and a reverse primer containing in its 3′-side the base sequence of SEQ ID NO:30 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence;

(A-2) a set of a forward primer containing in its 3′-side the base sequence of SEQ ID NO:26 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence, and a reverse primer containing in its 3′-side the base sequence of SEQ ID NO:31 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence;

(A-3) a set of a forward primer containing in its 3′-side the base sequence of SEQ ID NO:27 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence, and a reverse primer containing in its 3′-side the base sequence of SEQ ID NO:30 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence;

(A-4) a set of a forward primer containing in its 3′-side the base sequence of SEQ ID NO:27 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence, and a reverse primer containing in its 3′-side the base sequence of SEQ ID NO:31 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence;

(A-5) a set of a forward primer containing in its 3′-side the base sequence of SEQ ID NO:28 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in the base sequence, and a reverse primer containing in its 3′-side the base sequence of SEQ ID NO:30 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence;

(A-6) a set of a forward primer containing in its 3′-side the base sequence of SEQ ID NO:28 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence, and a reverse primer containing in its 3′-side the base sequence of SEQ ID NO:31 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence;

(A-7) a set of a forward primer containing in its 3′-side the base sequence of SEQ ID NO:29 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence, and a reverse primer containing in its 3′-side the base sequence of SEQ ID NO:30 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence;

(A-8) a set of a forward primer containing in its 3′-side the base sequence of SEQ ID NO:29 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence, and a reverse primer containing in its 3′-side the base sequence of SEQ ID NO:31 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence;

(B-1) a set of a forward primer containing in its 3′-side the base sequence of SEQ ID NO:58 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence, and a reverse primer containing in its 3′-side the base sequence of SEQ ID NO:59 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence;

(C-1) a set of a forward primer containing in its 3′-side the base sequence of SEQ ID NO:32 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence, and a reverse primer containing in its 3′-side the base sequence of SEQ ID NO:37 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence;

(D-1) a set of a forward primer containing in its 3′-side the base sequence of SEQ ID NO:33 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence, and a reverse primer containing in its 3′-side the base sequence of SEQ ID NO:38 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence;

(E-1) a set of a forward primer containing in its 3′-side the base sequence of SEQ ID NO:34 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in the base sequence, and a reverse primer containing in its 3′-side the base sequence of SEQ ID NO:38 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence;

(F-1) a set of a forward primer containing in its 3′-side the base sequence of SEQ ID NO:34 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence, and a reverse primer containing in its 3′-side the base sequence of SEQ ID NO:39 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence;

(G-1) a set of a forward primer containing in its 3′-side the base sequence of SEQ ID NO:34 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence, and a reverse primer containing in its 3′-side the base sequence of SEQ ID NO:40 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence;

(H-1) a set of a forward primer containing in its 3′-side the base sequence of SEQ ID NO:35 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in the base sequence, and a reverse primer containing in its 3′-side the base sequence of SEQ ID NO:39 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence;

(I-1) a set of a forward primer containing in its 3′-side the base sequence of SEQ ID NO:35 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence, and a reverse primer containing in its 3′-side the base sequence of SEQ ID NO:40 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence;

(I-2) a set of a forward primer containing in its 3′-side the base sequence of SEQ ID NO:60 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence, and a reverse primer containing in its 3′-side the base sequence of SEQ ID NO:61 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence;

(I-3) a set of a forward primer containing in its 3′-side the base sequence of SEQ ID NO:62 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence, and a reverse primer containing in its 3′-side the base sequence of SEQ ID NO:61 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence;

(J-1) a set of a forward primer containing in its 3′-side the base sequence of SEQ ID NO:35 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence, and a reverse primer containing in its 3′-side the base sequence of SEQ ID NO:41 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence;

(K-1) a set of a forward primer containing in its 3′-side the base sequence of SEQ ID NO:36 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence, and a reverse primer containing in its 3′-side the base sequence of SEQ ID NO:39 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in the base sequence;

(L-1) a set of a forward primer containing in its 3′-side the base sequence of SEQ ID NO:36 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence, and a reverse primer containing in its 3′-side the base sequence of SEQ ID NO:40 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence; and

(M-1) a set of a forward primer containing in its 3′-side the base sequence of SEQ ID NO:63 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence, and a reverse primer containing in its 3′-side the base sequence of SEQ ID NO:64 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence wherein the primer set further comprises a probe containing an oligonucleotide portion, wherein the ends of the oligonucleotide portion are modified with a fluorescent substance and a quencher substance, respectively.

2. A method of detecting Listeria monocytogenes , comprising a step of amplifying a partial region of lmo0084 gene or lmo2736 gene by a nucleic acid amplification method using the primer set according to claim 1 .

3. The method according to claim 2 , wherein the amplification of the partial region is carried out by a PCR method or an isothermal amplification method.

4. The method according to claim 3 , wherein the isothermal amplification method is a loop-mediated isothermal amplification method.

5. The method according to claim 3 , wherein the PCR method is a real-time PCR method.

6. A primer set for detection of Listeria monocytogenes , comprising any of the following sets:

(A-9) a set of a mixed forward primer containing in its 3′-side the base sequence of SEQ ID NO:67, and a mixed reverse primer containing in its 3′-side the base sequence of SEQ ID NO:69;

(A-10) a set of a mixed forward primer containing in its 3′-side the base sequence of SEQ ID NO:68, and a mixed reverse primer containing in its 3′-side the base sequence of SEQ ID NO:69;

(D-2) a set of a mixed forward primer containing in its 3′-side the base sequence of SEQ ID NO:70, and a mixed reverse primer containing in its 3′-side the base sequence of SEQ ID NO:74;

(E-2) a set of a mixed forward primer containing in its 3′-side the base sequence of SEQ ID NO:71, and a mixed reverse primer containing in its 3′-side the base sequence of SEQ ID NO:74;

(F-2) a set of a mixed forward primer containing in its 3′-side the base sequence of SEQ ID NO:71, and a mixed reverse primer containing in its 3′-side the base sequence of SEQ ID NO:75;

(G-2) a set of a mixed forward primer containing in its 3′-side the base sequence of SEQ ID NO:71, and a mixed reverse primer containing in its 3′-side the base sequence of SEQ ID NO:76;

(H-2) a set of a mixed forward primer containing in its 3′-side the base sequence of SEQ ID NO:72, and a mixed reverse primer containing in its 3′-side the base sequence of SEQ ID NO:75;

(I-4) a set of a mixed forward primer containing in its 3′-side the base sequence of SEQ ID NO:72, and a mixed reverse primer containing in its 3′-side the base sequence of SEQ ID NO:76;

(J-2) a set of a mixed forward primer containing in its 3′-side the base sequence of SEQ ID NO:72, and a reverse primer containing in its 3′-side the base sequence of SEQ ID NO:41 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence;

(K-3) a set of a mixed forward primer containing in its 3′-side the base sequence of SEQ ID NO:73, and a mixed reverse primer containing in its 3′-side the base sequence of SEQ ID NO:75;

(L-2) a set of a mixed forward primer containing in its 3′-side the base sequence of SEQ ID NO:73, and a mixed reverse primer containing in its 3′-side the base sequence of SEQ ID NO:76;

(N-1) a set of a mixed forward primer containing in its 3′-side the base sequence of SEQ ID NO:71, and a reverse primer containing in its 3′-side the base sequence of SEQ ID NO:41 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence; and

(O-1) a set of a mixed forward primer containing in its 3′-side the base sequence of SEQ ID NO:73, and a reverse primer containing in its 3′-side the base sequence of SEQ ID NO:41 or a sequence which is the same as said base sequence except that not more than 4 bases are substituted at a genetic polymorphism site(s) in said base sequence wherein the primer set further comprises a probe containing an oligonucleotide portion, wherein the ends of the oligonucleotide portion are modified with a fluorescent substance and a quencher substance, respectively.

7. A method of detecting Listeria monocytogenes , comprising a step of amplifying a partial region of lmo0084 gene or lmo2736 gene by a nucleic acid amplification method using the primer set according to claim 6 .

8. A probe for detection of Listeria monocytogenes by real-time PCR, comprising an oligonucleotide portion having the base sequence of SEQ ID NO:77, SEQ ID NOs:80 to 82, SEQ ID NO:85, wherein in SEQ ID NO:85 ngaan is tgaaa or cgaac; (or SEQ ID NO:86, wherein in SEQ ID NO:86, ngcaan is ggcaag or cgcaac; and wherein the oligonucleotide portion has ends modified with a fluorescent substance and a quencher substance, respectively.

9. A primer-probe set for real-time PCR for detection of Listeria monocytogenes , comprising any of the following sets of primers and a probe:

[1] a set of a forward primer containing in its 3′-side the base sequence of SEQ ID NO:67, a reverse primer containing in its 3′-side the base sequence of SEQ ID NO:69, and a probe containing an oligonucleotide portion having the base sequence of SEQ ID NO:77 or 80;

[2] a set of a forward primer containing in its 3′-side the base sequence of SEQ ID NO:67, a reverse primer containing in its 3′-side the base sequence of SEQ ID NO:69, and a mixed probe containing an oligonucleotide portion having the base sequence of SEQ ID NO:85, wherein in SEQ ID NO:85 ngaan is tgaaa or cgaac;

[3] a set of a forward primer containing in its 3′-side the base sequence of SEQ ID NO:68, a reverse primer containing in its 3′-side the base sequence of SEQ ID NO:69, and a probe containing an oligonucleotide portion having the base sequence of SEQ ID NO:77 or 80;

[4] a set of a forward primer containing in its 3′-side the base sequence of SEQ ID NO:68, a reverse primer containing in its 3′-side the base sequence of SEQ ID NO:69, and a mixed probe containing an oligonucleotide portion having the base sequence of SEQ ID NO:85, wherein in SEQ ID NO:85 ngaan is tgaaa or cgaac;

[5] a set of a forward primer containing in its 3′-side the base sequence of SEQ ID NO:32, a reverse primer containing in its 3′-side the base sequence of SEQ ID NO:37, and a probe containing an oligonucleotide portion having the base sequence of SEQ ID NO:81;

[6] a set of a forward primer containing in its 3′-side the base sequence of SEQ ID NO:70, a reverse primer containing in its 3′-side the base sequence of SEQ ID NO:74, and a probe containing an oligonucleotide portion having the base sequence of SEQ ID NO:82; and

[7] a set of a forward primer containing in its 3′-side the base sequence of SEQ ID NO:72, a reverse primer containing in its 3′-side the base sequence of SEQ ID NO:76, and a mixed probe containing an oligonucleotide portion having the base sequence of SEQ ID NO:86, wherein in SEQ ID NO:86, ngcaan is ggcaag or cgcaac; and

wherein each of the oligonucleotide portions of the probes has ends modified with a fluorescent substance and a quencher substance, respectively.

Assignments (2)
CHANGE OF NAME Recorded Mar 25, 2021
From: NIPPON FLOUR MILLS CO., LTD.
To: NIPPN CORPORATION
Reel/Frame 055714/0801 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2020
From: TSUNA, MIKA; HARADA, YOSHITAKA; SETO, YASUHIRO; TAKASAKI, KAZUTO
To: NIPPON FLOUR MILLS CO., LTD.; FASMAC CO., LTD.
Reel/Frame 052400/0400 →
Priority Claims (1)
JP 2017-141201 · Jul 20, 2017 · national
Continuity (1)
Related Publication 20210024979A1 · Jan 28, 2021